ArticleFrontiers in cardiovascular medicine2025
Association between the atherogenic index of plasma, body mass index, and cardiovascular diseases in Chinese middle and old-aged adults: a mediation analysis.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Evidence has emerged that suggests the atherogenic index of plasma (AIP), as determined by blood lipid levels, is a valuable predictor of the onset of cardiovascular diseases. The correlation between AIP and cardiovascular diseases may be facilitated by body mass index (BMI), as atherosclerosis is prevalent in overweight and obese populations. In order to assess the combined predictive value of the AIP and BMI in predicting outcomes associated with cardiovascular diseases, this study sought to determine if BMI mediates the relationship between the AIP and cardiovascular disease risk. Methods: Participants in this study were those who were without cardiovascular diseases at baseline and were members of the China Health and Retirement Longitudinal Study (CHARLS). We performed adjusted regression analysis and mediation. AIP was calculated using the logarithm of the ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C). The estimated body weight and height were used to calculate the BMI. Results: This study included 5468 participants. Cardiovascular diseases were highly linked with both BMI and AIP. In contrast to those with a lower AIP (median level) and BMI <24, those with an elevated AIP and increased BMI presented a higher risk for developing cardiovascular conditions (HR: 1.789; 95% CI: 1.491-2.147). Additionally, about 30.57% of the connection between AIP and cardiovascular diseases was strongly mediated by BMI. Conclusions: Among Chinese adults in their middle and advanced years, the AIP and BMI jointly have been associated to a higher risk of cardiovascular diseases, and BMI could serve as a mediator in this connection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.